NWK Group’s Abiomed Inc ABMD Stock Holding History

NWK Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8	Closed	-$2K	–	265
2020 Q2	$2K	Buy	+8	New	+$1.61K	﹤0.01%	248

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NWK Group's ABMD Position: Q3 2020 in Review

NWK Group sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 8 shares — an estimated $2K sold.

NWK Group first reported a position in ABMD in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

NWK Group reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
NWK Group sold 8 Abiomed Inc shares in Q3 2020, an estimated $2K.
NWK Group first reported a position in Abiomed Inc in Q2 2020 and held it in 1 quarter.
NWK Group's Abiomed Inc position peaked at $2K in Q2 2020.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on NWK Group's 13F filing for Q3 2020, filed 16 Nov 2020.